SCHEMBL3919908

SCHEMBL3919908

COc1ccc(CNC(=O)C2(NC(=O)OC(C)(C)C)CCN(C(=O)O)CC2)cc1

nearest known ligand 0.48

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 3/20 0.48
LMNA P02545 2/20 0.48
MAPT P10636 2/20 0.48
ALDH1A1 P00352 3/20 0.47
KDM4E B2RXH2 1/20 0.42
NPC1 O15118 4/20 0.42
RAB9A P51151 3/20 0.42
TP53 P04637 3/20 0.42
KMT2A Q03164 2/20 0.41
MEN1 O00255 1/20 0.41
EPHX2 P34913 1/20 0.41
NR1H4 Q96RI1 1/20 0.41
L3MBTL1 Q9Y468 1/20 0.41
NAMPT P43490 1/20 0.40
PPIA P62937 1/20 0.40
PKM P14618 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2777683 0.92 SMN1; SMN2 (0.57) SMN1; SMN2LMNAMAPTALDH1A1NPC1
SCHEMBL1973194 0.88 GAA (0.50) SMN1; SMN2ALDH1A1NPC1KMT2AMEN1
SCHEMBL1001879 0.80 SMN1; SMN2 (0.57) SMN1; SMN2LMNAMAPTALDH1A1KMT2A
SCHEMBL13510871 0.78 GAA (0.52) SMN1; SMN2ALDH1A1NPC1KMT2AMEN1
SCHEMBL19033759 0.77 CYP2C19 (0.54) SMN1; SMN2LMNAALDH1A1NPC1RAB9A
SCHEMBL4400570 0.77 CTSB (0.56) SMN1; SMN2LMNAALDH1A1KDM4EKMT2A
SCHEMBL14273893 0.77 HDAC1 (0.51) LMNAALDH1A1NPC1RAB9AKMT2A
SCHEMBL3662863 0.76 SMN1; SMN2 (0.50) SMN1; SMN2LMNAALDH1A1NPC1RAB9A
SCHEMBL7652554 0.75 NPC1 (0.58) SMN1; SMN2LMNAMAPTALDH1A1NPC1
SCHEMBL3491340 0.75 NAMPT (0.46) SMN1; SMN2LMNAMAPTTP53KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2029592-A1 PHARMACEUTICAL COMPOUNDS Astex Therapeutics Limited (GB) 2009-03-04 EP disclosed
WO-2007125325-A1 PHARMACEUTICAL COMPOUNDS ASTEX THERAPEUTICS LIMITED (GB) 2007-11-08 WO disclosed